Although significant progress has been made in treating cardiovascular disease (CVD) over the past decades, knowledge of sex-specific differences in the disease treatment have lagged behind.

Data access has been approved for a study to compare the incremental costs, health benefits, outcomes and overall cost-effectiveness of several new tests for prostate cancer risk assessment.

We live in a data filled world. In recent years, many of us have become increasingly aware of this fact and vigilant about how our data is protected and used. But do we really know the value of this data for improving the health and social well being of our society?